- Home
- SEPN vs TECX Comparison
SEPN vs TECX Comparison
Compare SEPN & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEPN
- TECX
- Stock Information
- Founded
- SEPN 2022
- TECX 2019
- Country
- SEPN United States
- TECX United States
- Employees
- SEPN N/A
- TECX N/A
- Industry
- SEPN
- TECX
- Sector
- SEPN
- TECX
- Exchange
- SEPN NYSE
- TECX Nasdaq
- Market Cap
- SEPN 631.0M
- TECX 746.6M
- IPO Year
- SEPN 2024
- TECX 2018
- Fundamental
- Price
- SEPN $5.70
- TECX $17.00
- Analyst Decision
- SEPN Buy
- TECX Strong Buy
- Analyst Count
- SEPN 4
- TECX 5
- Target Price
- SEPN $33.00
- TECX $77.75
- AVG Volume (30 Days)
- SEPN 420.0K
- TECX 226.6K
- Earning Date
- SEPN 03-27-2025
- TECX 03-20-2025
- Dividend Yield
- SEPN N/A
- TECX N/A
- EPS Growth
- SEPN N/A
- TECX N/A
- EPS
- SEPN N/A
- TECX N/A
- Revenue
- SEPN $1,075,000.00
- TECX N/A
- Revenue This Year
- SEPN N/A
- TECX N/A
- Revenue Next Year
- SEPN N/A
- TECX N/A
- P/E Ratio
- SEPN N/A
- TECX N/A
- Revenue Growth
- SEPN 611.92
- TECX N/A
- 52 Week Low
- SEPN $4.17
- TECX $1.40
- 52 Week High
- SEPN $28.99
- TECX $61.07
- Technical
- Relative Strength Index (RSI)
- SEPN N/A
- TECX 31.98
- Support Level
- SEPN N/A
- TECX $20.35
- Resistance Level
- SEPN N/A
- TECX $23.06
- Average True Range (ATR)
- SEPN 0.00
- TECX 2.01
- MACD
- SEPN 0.00
- TECX 0.13
- Stochastic Oscillator
- SEPN 0.00
- TECX 4.19
About SEPN SEPTERNA INC
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.